Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Human Chorionic Gonadotropin (HCG), including the following market information:
Major competitors identified in this market include EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, LLC, Scrippslabs, Leebio, Kamiya Biomedical Company, Sanzyme, Cigna, etc.
Based on the Region:
- Global Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Human Chorionic Gonadotropin (HCG) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Human Chorionic Gonadotropin (HCG) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Human Chorionic Gonadotropin (HCG) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, LLC, Scrippslabs, Leebio, Kamiya Biomedical Company, Sanzyme, Cigna, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Natural Source Extraction
- Recombinant DNA Technology
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Industry
1.7 COVID-19 Impact: Human Chorionic Gonadotropin (HCG) Market Trends
2 GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) QUARTERLY MARKET SIZE ANALYSIS
2.1 Human Chorionic Gonadotropin (HCG) Business Impact Assessment - COVID-19
2.1.1 Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Human Chorionic Gonadotropin (HCG) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Human Chorionic Gonadotropin (HCG) Factory Price by Manufacturers
3.3 Location of Key Manufacturers Human Chorionic Gonadotropin (HCG) Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
3.5 Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON HUMAN CHORIONIC GONADOTROPIN (HCG) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Natural Source Extraction
1.4.2 Recombinant DNA Technology
4.2 By Type, Global Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021
4.2.1 By Type, Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020-2021
4.2.2 By Type, Global Human Chorionic Gonadotropin (HCG) Price, 2020-2021
5 IMPACT OF COVID-19 ON HUMAN CHORIONIC GONADOTROPIN (HCG) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Female Infertility Treatment
5.5.2 Oligospermic Treatment
5.5.3 Cryptorchidism Treatment
5.5.4 Others
5.2 By Application, Global Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021
5.2.1 By Application, Global Human Chorionic Gonadotropin (HCG) Market Size by Application, 2019-2021
5.2.2 By Application, Global Human Chorionic Gonadotropin (HCG) Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 EMD Serono, Inc
7.1.1 EMD Serono, Inc Business Overview
7.1.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Introduction
7.1.4 EMD Serono, Inc Response to COVID-19 and Related Developments
7.2 Ferring B.V
7.2.1 Ferring B.V Business Overview
7.2.2 Ferring B.V Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Introduction
7.2.4 Ferring B.V Response to COVID-19 and Related Developments
7.3 Merck & Co., Inc
7.3.1 Merck & Co., Inc Business Overview
7.3.2 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Introduction
7.3.4 Merck & Co., Inc Response to COVID-19 and Related Developments
7.4 Bristol Myers Squibb Company
7.4.1 Bristol Myers Squibb Company Business Overview
7.4.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Introduction
7.4.4 Bristol Myers Squibb Company Response to COVID-19 and Related Developments
7.5 Fresenius Kabi AG, LLC
7.5.1 Fresenius Kabi AG, LLC Business Overview
7.5.2 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Introduction
7.5.4 Fresenius Kabi AG, LLC Response to COVID-19 and Related Developments
7.6 Scrippslabs
7.6.1 Scrippslabs Business Overview
7.6.2 Scrippslabs Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Introduction
7.6.4 Scrippslabs Response to COVID-19 and Related Developments
7.7 Leebio
7.7.1 Leebio Business Overview
7.7.2 Leebio Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.7.3 Leebio Human Chorionic Gonadotropin (HCG) Product Introduction
7.7.4 Leebio Response to COVID-19 and Related Developments
7.8 Kamiya Biomedical Company
7.8.1 Kamiya Biomedical Company Business Overview
7.8.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Introduction
7.8.4 Kamiya Biomedical Company Response to COVID-19 and Related Developments
7.9 Sanzyme
7.9.1 Sanzyme Business Overview
7.9.2 Sanzyme Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Product Introduction
7.9.4 Sanzyme Response to COVID-19 and Related Developments
7.10 Cigna
7.10.1 Cigna Business Overview
7.10.2 Cigna Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.10.3 Cigna Human Chorionic Gonadotropin (HCG) Product Introduction
7.10.4 Cigna Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Human Chorionic Gonadotropin (HCG) Supply Chain Analysis
8.1.1 Human Chorionic Gonadotropin (HCG) Supply Chain Analysis
8.1.2 Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Human Chorionic Gonadotropin (HCG) Distribution Channels
8.2.2 Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Distribution Channels
8.2.3 Human Chorionic Gonadotropin (HCG) Distributors
8.3 Human Chorionic Gonadotropin (HCG) Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Industry
1.7 COVID-19 Impact: Human Chorionic Gonadotropin (HCG) Market Trends
2 GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) QUARTERLY MARKET SIZE ANALYSIS
2.1 Human Chorionic Gonadotropin (HCG) Business Impact Assessment - COVID-19
2.1.1 Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Human Chorionic Gonadotropin (HCG) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Human Chorionic Gonadotropin (HCG) Factory Price by Manufacturers
3.3 Location of Key Manufacturers Human Chorionic Gonadotropin (HCG) Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
3.5 Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON HUMAN CHORIONIC GONADOTROPIN (HCG) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Natural Source Extraction
1.4.2 Recombinant DNA Technology
4.2 By Type, Global Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021
4.2.1 By Type, Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020-2021
4.2.2 By Type, Global Human Chorionic Gonadotropin (HCG) Price, 2020-2021
5 IMPACT OF COVID-19 ON HUMAN CHORIONIC GONADOTROPIN (HCG) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Female Infertility Treatment
5.5.2 Oligospermic Treatment
5.5.3 Cryptorchidism Treatment
5.5.4 Others
5.2 By Application, Global Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021
5.2.1 By Application, Global Human Chorionic Gonadotropin (HCG) Market Size by Application, 2019-2021
5.2.2 By Application, Global Human Chorionic Gonadotropin (HCG) Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 EMD Serono, Inc
7.1.1 EMD Serono, Inc Business Overview
7.1.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Introduction
7.1.4 EMD Serono, Inc Response to COVID-19 and Related Developments
7.2 Ferring B.V
7.2.1 Ferring B.V Business Overview
7.2.2 Ferring B.V Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Introduction
7.2.4 Ferring B.V Response to COVID-19 and Related Developments
7.3 Merck & Co., Inc
7.3.1 Merck & Co., Inc Business Overview
7.3.2 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Introduction
7.3.4 Merck & Co., Inc Response to COVID-19 and Related Developments
7.4 Bristol Myers Squibb Company
7.4.1 Bristol Myers Squibb Company Business Overview
7.4.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Introduction
7.4.4 Bristol Myers Squibb Company Response to COVID-19 and Related Developments
7.5 Fresenius Kabi AG, LLC
7.5.1 Fresenius Kabi AG, LLC Business Overview
7.5.2 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Introduction
7.5.4 Fresenius Kabi AG, LLC Response to COVID-19 and Related Developments
7.6 Scrippslabs
7.6.1 Scrippslabs Business Overview
7.6.2 Scrippslabs Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Introduction
7.6.4 Scrippslabs Response to COVID-19 and Related Developments
7.7 Leebio
7.7.1 Leebio Business Overview
7.7.2 Leebio Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.7.3 Leebio Human Chorionic Gonadotropin (HCG) Product Introduction
7.7.4 Leebio Response to COVID-19 and Related Developments
7.8 Kamiya Biomedical Company
7.8.1 Kamiya Biomedical Company Business Overview
7.8.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Introduction
7.8.4 Kamiya Biomedical Company Response to COVID-19 and Related Developments
7.9 Sanzyme
7.9.1 Sanzyme Business Overview
7.9.2 Sanzyme Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Product Introduction
7.9.4 Sanzyme Response to COVID-19 and Related Developments
7.10 Cigna
7.10.1 Cigna Business Overview
7.10.2 Cigna Human Chorionic Gonadotropin (HCG) Quarterly Production and Revenue, 2020
7.10.3 Cigna Human Chorionic Gonadotropin (HCG) Product Introduction
7.10.4 Cigna Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Human Chorionic Gonadotropin (HCG) Supply Chain Analysis
8.1.1 Human Chorionic Gonadotropin (HCG) Supply Chain Analysis
8.1.2 Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Human Chorionic Gonadotropin (HCG) Distribution Channels
8.2.2 Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Distribution Channels
8.2.3 Human Chorionic Gonadotropin (HCG) Distributors
8.3 Human Chorionic Gonadotropin (HCG) Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Assessment
Table 9. COVID-19 Impact: Human Chorionic Gonadotropin (HCG) Market Trends
Table 10. COVID-19 Impact Global Human Chorionic Gonadotropin (HCG) Market Size
Table 11. Global Human Chorionic Gonadotropin (HCG) Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Human Chorionic Gonadotropin (HCG) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Human Chorionic Gonadotropin (HCG) Market Growth Drivers
Table 17. Global Human Chorionic Gonadotropin (HCG) Market Restraints
Table 18. Global Human Chorionic Gonadotropin (HCG) Market Opportunities
Table 19. Global Human Chorionic Gonadotropin (HCG) Market Challenges
Table 20. Key Manufacturers Human Chorionic Gonadotropin (HCG) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Human Chorionic Gonadotropin (HCG) Market Size, 2019 (K Units) & (US$ Million)
Table 22. Human Chorionic Gonadotropin (HCG) Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Human Chorionic Gonadotropin (HCG) Manufacturing Plants
Table 24. Key Manufacturers Human Chorionic Gonadotropin (HCG) Market Served
Table 25. Date of Key Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
Table 26. Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020, (US$ Million)
Table 29. Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020 (K Units)
Table 30. Global Human Chorionic Gonadotropin (HCG) Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Human Chorionic Gonadotropin (HCG) Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Human Chorionic Gonadotropin (HCG) Market Size by Application, 2020-2021 (K Units)
Table 33. Global Human Chorionic Gonadotropin (HCG) Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Human Chorionic Gonadotropin (HCG) Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Human Chorionic Gonadotropin (HCG) Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 38. US Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 43. Germany Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 50. China Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. EMD Serono, Inc Business Overview
Table 58. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product
Table 60. EMD Serono, Inc Response to COVID-19 and Related Developments
Table 61. Ferring B.V Business Overview
Table 62. Ferring B.V Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Ferring B.V Human Chorionic Gonadotropin (HCG) Product
Table 64. Ferring B.V Response to COVID-19 and Related Developments
Table 65. Merck & Co., Inc Business Overview
Table 66. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product
Table 68. Merck & Co., Inc Response to COVID-19 and Related Developments
Table 69. Bristol Myers Squibb Company Business Overview
Table 70. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product
Table 72. Bristol Myers Squibb Company Response to COVID-19 and Related Developments
Table 73. Fresenius Kabi AG, LLC Business Overview
Table 74. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product
Table 76. Fresenius Kabi AG, LLC Response to COVID-19 and Related Developments
Table 77. Scrippslabs Business Overview
Table 78. Scrippslabs Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Scrippslabs Human Chorionic Gonadotropin (HCG) Product
Table 80. Scrippslabs Response to COVID-19 and Related Developments
Table 81. Leebio Business Overview
Table 82. Leebio Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Leebio Human Chorionic Gonadotropin (HCG) Product
Table 84. Leebio Response to COVID-19 and Related Developments
Table 85. Kamiya Biomedical Company Business Overview
Table 86. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product
Table 88. Kamiya Biomedical Company Response to COVID-19 and Related Developments
Table 89. Sanzyme Business Overview
Table 90. Sanzyme Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Sanzyme Human Chorionic Gonadotropin (HCG) Product
Table 92. Sanzyme Response to COVID-19 and Related Developments
Table 93. Cigna Business Overview
Table 94. Cigna Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Cigna Human Chorionic Gonadotropin (HCG) Product
Table 96. Cigna Response to COVID-19 and Related Developments
Table 97. Human Chorionic Gonadotropin (HCG) Distributors List
Table 98. Human Chorionic Gonadotropin (HCG) Customers List
Table 99. Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Assessment
Table 9. COVID-19 Impact: Human Chorionic Gonadotropin (HCG) Market Trends
Table 10. COVID-19 Impact Global Human Chorionic Gonadotropin (HCG) Market Size
Table 11. Global Human Chorionic Gonadotropin (HCG) Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Human Chorionic Gonadotropin (HCG) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Human Chorionic Gonadotropin (HCG) Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Human Chorionic Gonadotropin (HCG) Market Growth Drivers
Table 17. Global Human Chorionic Gonadotropin (HCG) Market Restraints
Table 18. Global Human Chorionic Gonadotropin (HCG) Market Opportunities
Table 19. Global Human Chorionic Gonadotropin (HCG) Market Challenges
Table 20. Key Manufacturers Human Chorionic Gonadotropin (HCG) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Human Chorionic Gonadotropin (HCG) Market Size, 2019 (K Units) & (US$ Million)
Table 22. Human Chorionic Gonadotropin (HCG) Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Human Chorionic Gonadotropin (HCG) Manufacturing Plants
Table 24. Key Manufacturers Human Chorionic Gonadotropin (HCG) Market Served
Table 25. Date of Key Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
Table 26. Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020, (US$ Million)
Table 29. Global Human Chorionic Gonadotropin (HCG) Market Size by Type, 2020 (K Units)
Table 30. Global Human Chorionic Gonadotropin (HCG) Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Human Chorionic Gonadotropin (HCG) Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Human Chorionic Gonadotropin (HCG) Market Size by Application, 2020-2021 (K Units)
Table 33. Global Human Chorionic Gonadotropin (HCG) Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Human Chorionic Gonadotropin (HCG) Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Human Chorionic Gonadotropin (HCG) Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 38. US Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 43. Germany Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (K Units)
Table 50. China Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. EMD Serono, Inc Business Overview
Table 58. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product
Table 60. EMD Serono, Inc Response to COVID-19 and Related Developments
Table 61. Ferring B.V Business Overview
Table 62. Ferring B.V Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Ferring B.V Human Chorionic Gonadotropin (HCG) Product
Table 64. Ferring B.V Response to COVID-19 and Related Developments
Table 65. Merck & Co., Inc Business Overview
Table 66. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product
Table 68. Merck & Co., Inc Response to COVID-19 and Related Developments
Table 69. Bristol Myers Squibb Company Business Overview
Table 70. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product
Table 72. Bristol Myers Squibb Company Response to COVID-19 and Related Developments
Table 73. Fresenius Kabi AG, LLC Business Overview
Table 74. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product
Table 76. Fresenius Kabi AG, LLC Response to COVID-19 and Related Developments
Table 77. Scrippslabs Business Overview
Table 78. Scrippslabs Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Scrippslabs Human Chorionic Gonadotropin (HCG) Product
Table 80. Scrippslabs Response to COVID-19 and Related Developments
Table 81. Leebio Business Overview
Table 82. Leebio Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Leebio Human Chorionic Gonadotropin (HCG) Product
Table 84. Leebio Response to COVID-19 and Related Developments
Table 85. Kamiya Biomedical Company Business Overview
Table 86. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product
Table 88. Kamiya Biomedical Company Response to COVID-19 and Related Developments
Table 89. Sanzyme Business Overview
Table 90. Sanzyme Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Sanzyme Human Chorionic Gonadotropin (HCG) Product
Table 92. Sanzyme Response to COVID-19 and Related Developments
Table 93. Cigna Business Overview
Table 94. Cigna Human Chorionic Gonadotropin (HCG) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Cigna Human Chorionic Gonadotropin (HCG) Product
Table 96. Cigna Response to COVID-19 and Related Developments
Table 97. Human Chorionic Gonadotropin (HCG) Distributors List
Table 98. Human Chorionic Gonadotropin (HCG) Customers List
Table 99. Covid-19 Impact on Human Chorionic Gonadotropin (HCG) Customers
LIST OF FIGURES
Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
Figure 2. Human Chorionic Gonadotropin (HCG) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Human Chorionic Gonadotropin (HCG) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Human Chorionic Gonadotropin (HCG) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Human Chorionic Gonadotropin (HCG) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Human Chorionic Gonadotropin (HCG) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Market Share, 2019-2021
Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
Figure 2. Human Chorionic Gonadotropin (HCG) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Human Chorionic Gonadotropin (HCG) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Human Chorionic Gonadotropin (HCG) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Human Chorionic Gonadotropin (HCG) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Human Chorionic Gonadotropin (HCG) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Human Chorionic Gonadotropin (HCG) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size Market Share, 2019-2021
